September 19/21 2019 – Hotel Kempinski, Berchtesgaden
Thursday, September 19th
| Dinner at a typical German “Almhütte” | |||
| 18:00 | Start of the hiking trip | ||
| 18:30 | Bus departure to the “Almhütte” | ||
Friday, September 20th
| Welcome | ||||||
| 09:00 | 09:10 | Welcome and Introduction | ||||
| 09:10 | 10:30 | Introduction round | ||||
| 10:30 – 11:00 | Coffee Break | |||||
| Population studies and big data in microbiome research | ||||||
| 11:00 | 11:25 | Global evolution and preservation of human gut bacteria | Mathieu Groussin, Cambridge/Massachusetts | |||
| 11:25 | 11:50 | Obese individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and Composition | Andre Franke, Kiel | |||
| 11:50 | 12:20 | A gut choice: and how the gut tastes calories | Diego V. Bohórquez, Durham/North Carolina Winston Liu |
|||
| 12:20 | 12:50 | Drug-Microbiome-Interaction: General considerations and examples from human studies | Vanessa Stadlbauer-Köllner, Graz Angela Horvath |
|||
| 12:50 | 13:20 | Discussion round | ||||
| 13:20 – 14:20 | Buffet Lunch | |||||
| Metabolites and Immunometabolism | ||||||
| 14:20 | 14:50 | Identification of host-microbial metabolite interactions for therapy response prediction in IBD | Stefan Schreiber, Kiel Konrad Aden |
|||
| 14:50 | 15:15 | The Role of Secondary Bile Acids in Intestinal Inflammation | Sidhartha Sinha, Stanford | |||
| 15:15 | 15:40 | Role of Indoleamine 2, 3-dioxygenase in metabolic diseases through gut microbiota | Soraya Taleb, Paris | |||
| 15:40– 16:00 | Coffee Break | |||||
| Metabolites and Immunometabolism | ||||||
| 16:00 | 16:30 | Energy metabolism and hormones – news from the gut | Barbara Obermayer-Pietsch, Graz Valentin Borzan |
|||
| 16:30 | 17:00 | Latest developments in metametabolomics of gut microbiomes | Philippe Schmitt-Kopplin, München Alesia Walker |
|||
| 17:00 | 17:30 | Discussion round | ||||
| 19:30 | Dinner at Le Ciel | |||||
Saturday, September 21st
| The microbiome in cancer diagnosis and treatment | |||
| 09:00 | 09:30 | The intestinal microbiota as diagnostic and therapeutic factor in colorectal carcinoma | Michael Scharl, Zürich Ana Montalban-Arques |
| 09:30 | 10:00 | Licensing of Treatment Response- do microbiota matter in cancer therapy ? | Philip Rosenstiel, Kiel Felix Sommer |
| 10:00 | 10:30 | Discussion Round | |
| 10:30– 11:00 | Coffee Break | ||
| Microbiota – bacteria and beyond | |||
| 11:00 | 11:30 | The intestinal and biliary microbiome in the pathogenesis of primary sclerosing cholangitis (PSC) | Christoph Schramm, Hamburg Corinna Bang |
| 11:30 | 11:55 | Gut-Liver-Axis in the pathophysiology of decompensated liver cirrhosis and acute-on-chronic liver failure (ACLF) | Jonel Trebicka, Frankfurt |
| 11:55 | 12:25 | Translating microbiota research into therapies for liver disease | Bernd Schnabl, San Diego Sonja Lang |
| 12:25 | 12:50 | Mapping Microbiomes at the Micron Scale | Gary Borisy, Cambridge/Massachusetts |
| 12:50 | 13:30 | Discussion round/Final discussion/closing remarks | |
| 13:30 | Buffet Lunch | ||